Clinical Trial

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

Study acronym: CHERRY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2019-01-25; most recent amendment 2026-04-29.
Status change: Recruiting → Active, Not Recruiting 2019-07-23
Status change: Withheld → Recruiting 2019-02-13
Trial Details
NCT Number NCT03818880
Lead Sponsor SightGlass Vision, Inc.
Collaborators: University of Waterloo
Conditions Myopia, Progressive
Enrollment 10 participants
Start Date 2018-12-18
Primary Completion 2022-04-21 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05